Hana E. Baker

601 total citations
22 papers, 462 citations indexed

About

Hana E. Baker is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hana E. Baker has authored 22 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hana E. Baker's work include Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (7 papers) and Cardiovascular Function and Risk Factors (6 papers). Hana E. Baker is often cited by papers focused on Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (7 papers) and Cardiovascular Function and Risk Factors (6 papers). Hana E. Baker collaborates with scholars based in United States, Netherlands and France. Hana E. Baker's co-authors include Johnathan D. Tune, Adam G. Goodwill, Alexander Kiel, Timothy J. Kowalski, Galya Vassileva, Maureen Laverty, Gregory M. Dick, Joseph A. Hedrick, Frederique M. Poulet and Kieren J. Mather and has published in prestigious journals such as Diabetes, Journal of the American Society of Nephrology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hana E. Baker

21 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hana E. Baker United States	11	233	163	163	78	65	22	462
Christiné S. Rigsby United States	10	157 0.7×	100 0.6×	154 0.9×	87 1.1×	72 1.1×	11	410
Mobin Dib Germany	7	138 0.6×	71 0.4×	102 0.6×	92 1.2×	102 1.6×	8	352
M. Dodson Michael United States	13	285 1.2×	293 1.8×	212 1.3×	33 0.4×	134 2.1×	19	592
Ingo Uphues Germany	10	174 0.7×	206 1.3×	404 2.5×	103 1.3×	170 2.6×	17	617
Yukiko Kanda Japan	12	304 1.3×	304 1.9×	209 1.3×	51 0.7×	125 1.9×	20	611
Natalie C. Fredette United States	10	189 0.8×	72 0.4×	199 1.2×	110 1.4×	109 1.7×	16	576
Jin Shang China	11	74 0.3×	122 0.7×	173 1.1×	75 1.0×	62 1.0×	25	382
Masamitsu Iwasa Japan	14	92 0.4×	80 0.5×	166 1.0×	153 2.0×	47 0.7×	21	443
Masayoshi Ishizawa Japan	14	162 0.7×	55 0.3×	202 1.2×	55 0.7×	110 1.7×	25	429
Yuji Uchizono Japan	13	228 1.0×	437 2.7×	184 1.1×	70 0.9×	114 1.8×	24	626

Countries citing papers authored by Hana E. Baker

Since Specialization

Citations

This map shows the geographic impact of Hana E. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana E. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana E. Baker more than expected).

Fields of papers citing papers by Hana E. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hana E. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana E. Baker. The network helps show where Hana E. Baker may publish in the future.

Co-authorship network of co-authors of Hana E. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Hana E. Baker. A scholar is included among the top collaborators of Hana E. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hana E. Baker. Hana E. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Russell‐Hallinan, Adam, Frank Lezoualc’h, Giuseppe Matullo, et al.. (2025). Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy. Diabetes/Metabolism Research and Reviews. 41(6). e70081–e70081. 2 indexed citations

Collins, Kyla, Xinxin Yu, Brian A. Droz, et al.. (2023). GIPR Agonism Enhances TZD-Induced Insulin Sensitivity in Obese IR Mice. Diabetes. 73(2). 292–305. 8 indexed citations

Nair, Viji, Jennifer L. Harder, Jamal El Saghir, et al.. (2023). Interferon-γ (IFN-g) Signaling in Diabetic Kidney Disease (DKD) Associated with ESKD. Journal of the American Society of Nephrology. 34(11S). 37–37. 1 indexed citations

Tune, Johnathan D., Adam G. Goodwill, Hana E. Baker, et al.. (2022). Chronic high-rate pacing induces heart failure with preserved ejection fraction-like phenotype in Ossabaw swine. Basic Research in Cardiology. 117(1). 50–50. 3 indexed citations

Moyers, Julie S., Ryan J. Hansen, Jonathan W. Day, et al.. (2022). Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein. Journal of Pharmacology and Experimental Therapeutics. 382(3). 346–355. 41 indexed citations

Heuer, Josef G., Catalina M. Meyer, Hana E. Baker, et al.. (2022). Pharmacological Evaluation of a Pegylated Urocortin-1 Peptide in Experimental Autoimmune Disease Models. Journal of Pharmacology and Experimental Therapeutics. 382(3). 287–298.

Lezoualc’h, Frank, Lina Badimón, Hana E. Baker, et al.. (2022). Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality. Cardiovascular Research. 119(5). 1130–1145. 15 indexed citations

Moyers, Julie S., Ryan J. Hansen, Jonathan W. Day, et al.. (2021). Preclinical Characterization of Once Weekly Basal Insulin Fc (BIF). Journal of the Endocrine Society. 5(Supplement_1). A442–A442. 6 indexed citations

Tune, Johnathan D., Hana E. Baker, Zachary C. Berwick, et al.. (2020). Distinct hemodynamic responses to (pyr)apelin-13 in large animal models. American Journal of Physiology-Heart and Circulatory Physiology. 318(4). H747–H755. 2 indexed citations

10.

Tune, Johnathan D., Adam G. Goodwill, Alexander Kiel, et al.. (2019). Disentangling the Gordian knot of local metabolic control of coronary blood flow. American Journal of Physiology-Heart and Circulatory Physiology. 318(1). H11–H24. 15 indexed citations

11.

Baker, Hana E., Alexander Kiel, Ajit Regmi, et al.. (2019). Inhibition of sodium–glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization. Basic Research in Cardiology. 114(3). 25–25. 58 indexed citations

12.

Kiel, Alexander, Adam G. Goodwill, Hana E. Baker, Gregory M. Dick, & Johnathan D. Tune. (2018). Local metabolic hypothesis is not sufficient to explain coronary autoregulatory behavior. Basic Research in Cardiology. 113(5). 33–33. 34 indexed citations

13.

Neelamkavil, Santhosh, Andrew W. Stamford, Timothy J. Kowalski, et al.. (2018). Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 9(5). 457–461. 7 indexed citations

14.

Harlan, Shannon M., Kathleen M. Heinz-Taheny, John M. Sullivan, et al.. (2017). Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus–Driven Hypertension in Diverse Diabetic Models. Journal of the American Society of Nephrology. 29(2). 477–491. 26 indexed citations

15.

Okragly, Angela J., Matthew Hamang, Hana E. Baker, et al.. (2016). Elevated levels of Interleukin (IL)-33 induce bone pathology but absence of IL-33 does not negatively impact normal bone homeostasis. Cytokine. 79. 66–73. 9 indexed citations

16.

Dai, Xing, Andrew W. Stamford, Hong Liu, et al.. (2015). Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 25(22). 5291–5294. 5 indexed citations

17.

Xia, Yan, Samuel Chackalamannil, William J. Greenlee, et al.. (2011). Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 21(11). 3290–3296. 34 indexed citations

18.

Chackalamannil, Samuel, Hana E. Baker, Timothy J. Kowalski, et al.. (2010). Azabicyclic sulfonamides as potent 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1551–1554. 7 indexed citations

19.

Hong, Lan, Galya Vassileva, Li Liu, et al.. (2009). GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. Journal of Endocrinology. 201(2). 219–230. 132 indexed citations

20.

Biewenga, Jeike, Hana E. Baker, Siebe Swart, et al.. (1991). Nasal Secretions from Patients with Polyps and Healthy Individuals, Collected with a New Aspiration System: Evaluation of Total Protein and Immunoglobulin Concentrations. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 28(3). 260–266. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact